open access

Vol 6, No 4 (2004)
Published online: 2005-01-26
Get Citation

Effects of splenectomy on the general state and prognosis of patients with hematological proliferative disorders

Ewa Mendek-Czajkowska, Maciej Słomkowski, Sławomir Huszcza, Anna Sikorska, Renata K. Maryniak, Ewa Nita, Agnieszka Łuczak, Stanisław Maj, Alfred Jerzy Meissner, Lech Konopka
Chirurgia Polska 2004;6(4):211-219.

open access

Vol 6, No 4 (2004)
Published online: 2005-01-26

Abstract

Background: Splenectomy is an auxiliary treatment method applied to many disorders of the hematopoietic system also including myeloproliferative syndromes.
Material and methods: Splenectomy was performed in 50 patients with various hematological proliferative disorders. The main indications were: compression symptoms, hypersplenism and diagnostic excision. The post-splenectomy observation period ranged from 6 to 82 months (mean time 26 months).
Results: An improvement lasting not less than 6 months was achieved in 52% of patients. The best prognosis group included patients with a primary splenic marginal zone lymphoma; 5 long lasting clinical remissions and 3 deaths due to basic disease progression were reported (altogether 15 cases). The worst prognosis group included patients with primary myelofibrosis — no clinical remission was reported and 6 deaths occurred due to disease progression (out of 9 cases). A splenectomy due to hypersplenism resulted in an platelet increase of over 100 × 109/l (89% of patients) and white blood cell increases of over 3 × 109/l (all patients). The post-splenectomy mean increase of the red blood cell count in patients with hypersplenism was not large (0.07 × 1012/l). In two patients however, it reached 0.7 and 1.7 × 1012/ therefore blood transfusion could be avoided. In 22% of patients, serious post splenectomy clinical complications appeared including one death due to a cerebral hemorrhage. In 50% of patients thrombocytemia was observed and in 28% of patients, an asymptomatic thrombosis of the splenic vein occurred.
Conclusions: The best prognosis in patients with proliferative hematological disorders was found in the group with primary splenic marginal zone lymphoma, while respectively the worst prognosis concerned patients with primary myelofibrosis.

Abstract

Background: Splenectomy is an auxiliary treatment method applied to many disorders of the hematopoietic system also including myeloproliferative syndromes.
Material and methods: Splenectomy was performed in 50 patients with various hematological proliferative disorders. The main indications were: compression symptoms, hypersplenism and diagnostic excision. The post-splenectomy observation period ranged from 6 to 82 months (mean time 26 months).
Results: An improvement lasting not less than 6 months was achieved in 52% of patients. The best prognosis group included patients with a primary splenic marginal zone lymphoma; 5 long lasting clinical remissions and 3 deaths due to basic disease progression were reported (altogether 15 cases). The worst prognosis group included patients with primary myelofibrosis — no clinical remission was reported and 6 deaths occurred due to disease progression (out of 9 cases). A splenectomy due to hypersplenism resulted in an platelet increase of over 100 × 109/l (89% of patients) and white blood cell increases of over 3 × 109/l (all patients). The post-splenectomy mean increase of the red blood cell count in patients with hypersplenism was not large (0.07 × 1012/l). In two patients however, it reached 0.7 and 1.7 × 1012/ therefore blood transfusion could be avoided. In 22% of patients, serious post splenectomy clinical complications appeared including one death due to a cerebral hemorrhage. In 50% of patients thrombocytemia was observed and in 28% of patients, an asymptomatic thrombosis of the splenic vein occurred.
Conclusions: The best prognosis in patients with proliferative hematological disorders was found in the group with primary splenic marginal zone lymphoma, while respectively the worst prognosis concerned patients with primary myelofibrosis.
Get Citation

Keywords

splenectomy; hematological proliferative disorders; prognosis

About this article
Title

Effects of splenectomy on the general state and prognosis of patients with hematological proliferative disorders

Journal

Chirurgia Polska (Polish Surgery)

Issue

Vol 6, No 4 (2004)

Pages

211-219

Published online

2005-01-26

Bibliographic record

Chirurgia Polska 2004;6(4):211-219.

Keywords

splenectomy
hematological proliferative disorders
prognosis

Authors

Ewa Mendek-Czajkowska
Maciej Słomkowski
Sławomir Huszcza
Anna Sikorska
Renata K. Maryniak
Ewa Nita
Agnieszka Łuczak
Stanisław Maj
Alfred Jerzy Meissner
Lech Konopka

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaBy "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl